Abstract
Salbutamol solution is usually administered by nebuliser in a dose of 5 mg. Little evidence exists that this is the optimal dose for bronchodilatation or that this dose is without side-effects. Twelve patients with asthma were given increasing doses of salbutamol 1.5 mg, 3.0 mg, 7.5 mg, and placebo. Treatments were administered twice daily for four days in a double-blind manner. Measurements of ventilatory capacity, pulse rate, and tremor were recorded before and for three hours after treatment. There was a significant dose-related response for FEVI and peak flow rate. There was also a significant dose-related response in pulse rate and tremor. The incidence of palpitations was similarly related to dose. Plasma levels of salbutamol were measured before and after treatment with salbutamol and showed a dose related increase in salbutamol absorption which begins to be evident after the 3.0 mg dose. Three milligrams of salbutamol nebuliser solution may be an optimal dose, producing satisfactory bronchodilatation but fewer side-effects related to systemic absorption.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Lawford P., Jones B. J., Milledge J. S. Comparison of intravenous and nebulised salbutamol in initial treatment of severe asthma. Br Med J. 1978 Jan 14;1(6105):84–84. doi: 10.1136/bmj.1.6105.84. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Martin L. E., Rees J., Tanner R. J. Quantitative determination of salbutamol in plasma, as either its trimethylsilyl or t-butyldimethylsilyl ether, using a stable isotope multiple ion recording technique. Biomed Mass Spectrom. 1976 Aug;3(4):184–190. doi: 10.1002/bms.1200030408. [DOI] [PubMed] [Google Scholar]
- Tattersfield A. E., McNicol M. W. Salbutamol and isoproterenol. A double-blind trial to compare bronchodilator and cardiovascular activity. N Engl J Med. 1969 Dec 11;281(24):1323–1326. doi: 10.1056/NEJM196912112812402. [DOI] [PubMed] [Google Scholar]
- Williams S., Seaton A. Intravenous or inhaled salbutamol in severe acute asthma? Thorax. 1977 Oct;32(5):555–558. doi: 10.1136/thx.32.5.555. [DOI] [PMC free article] [PubMed] [Google Scholar]